• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHB2201575 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2022-09-02 Hebei Changshan Biochemical Pharmaceutical Co Ltd view
CYHB2201574 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2022-09-02 Hebei Changshan Biochemical Pharmaceutical Co Ltd view
CYHB2151090 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-12-15 Hebei Changshan Biochemical Pharmaceutical Co Ltd view
CYHB2150078 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-01-29 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2021-01-28 view
CYHB2150079 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-01-29 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2021-01-28 view
CYHB2100002 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-01-20 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2021-01-19 view
CYHB2100001 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-01-08 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2021-01-07 view
CYHB2050514 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(原6) Supplementary Application 2020-08-20 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2020-08-19 view
CYHB2050339 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-06-20 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2020-06-19 view
CYHB2050338 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2020-06-20 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2020-06-19 view
CYHB1904930 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-09-07 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2020-01-14 view
CYHB1904950 肝素钠注射液 Heparin Sodium Injection Chemical Drugs Supplementary Application 2019-09-07 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2020-11-17 view
CYHB1904951 肝素钠注射液 Heparin Sodium Injection Chemical Drugs Supplementary Application 2019-09-07 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2020-11-17 view
CYHB1904929 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-09-07 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd In Review 2019-09-06 view
CYHB1904245 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-06 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2019-12-30 view
CXHB1900001 艾本那肽注射液 Injection Chemical Drugs Supplementary Application 2019-01-10 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2019-03-26 view
CXHB1900002 艾本那肽注射液 Injection Chemical Drugs Supplementary Application 2019-01-10 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2019-03-26 view
CYHB1706515 肝素钠封管注射液 Heparin Sodium Injection Chemical Drugs Supplementary Application 2017-12-13 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2018-12-05 view
CYHB1706516 肝素钠封管注射液 Heparin Sodium Injection Chemical Drugs Supplementary Application 2017-12-13 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2018-12-05 view
CYHB1705602 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2017-09-13 河北常山生化药业股份有限公司 Hebei Changshan Biochemical Pharmaceutical Co Ltd Certificate Issued 2020-05-08 view